<i>CYP2D6</i> Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis
The long-term use of psychopharmacology medications in autism spectrum disorder (ASD) hitherto remains controversial due to a lack of evidence about safety and tolerability. In this regard, genotyping the metabolizing enzyme cytochrome P450 <i>(CYP) 2D6</i>, especially its extreme phenot...
Saved in:
Main Authors: | Pura Ballester (Author), Cristina Espadas (Author), Susana Almenara (Author), Jordi Barrachina (Author), Javier Muriel (Author), Enrique Ramos (Author), Natalia Toral (Author), César Belda (Author), Ana M. Peiró (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences
by: Javier Muriel, et al.
Published: (2023) -
Autism Spectrum Disorders: From genotypes to phenotypes
by: Valsamma Eapen
Published: (2015) -
Effect of Antibiotic Susceptibility and <i>CYP3A4/5</i> and <i>CYP2C19</i> Genotype on the Outcome of Vonoprazan-Containing <i>Helicobacter pylori</i> Eradication Therapy
by: Mitsushige Sugimoto, et al.
Published: (2020) -
Does ethnicity impact CYP2D6 genotype-phenotype relationships?
by: Trine Frederiksen, et al.
Published: (2023) -
Practice of CYP450 genotyping and phenotyping in children in a real-life setting
by: Frédérique Rodieux, et al.
Published: (2023)